Advertisement

Oral Cancer

  • Jean M. Bruch
  • Nathaniel S. Treister
Chapter

Abstract

Oral cancer imposes a significant burden on public health in the USA and many parts of the world. The morbidity of the disease and its treatment can be quite substantial, resulting in disfigurement, pain, impaired speech and swallowing, and overall decreased quality of life. Unfortunately, overall 5-year survival remains approximately 50 %, which has not improved significantly over time despite technological advances in treatment. This chapter outlines the epidemiology, major known risk factors, and clinical features of oral malignant and premalignant lesions as well as management guidelines.

Keywords

Oral cancer Squamous cell carcinoma Carcinogen Smokeless tobacco Synergistic effect Betel Dyskeratosis congenita Fanconi anemia Plummer–Vinson syndrome Sanguinaria Exophytic Tobacco Alcohol Fixation Induration Verrucous carcinoma Dysplasia Carcinoma in situ Cytology Biopsy Actinic cheilitis Leukoplakia Erythroplakia Proliferative verrucous leukoplakia Tobacco pouch keratosis Oral submucous fibrosis Lichen planus Cancer staging Metastasis Mucositis Osteoradionecrosis Xerostomia Radiation therapy Chemotherapy Hyperbaric oxygen therapy 

Sources

  1. Aldington S, Harwood M, Cox B, et al. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg. 2008;138:374–80.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Atkinson JC, Harvey KE, Domingo DL, et al. Oral and dental phenotype of dyskeratosis congenita. Oral Dis. 2008;14:419–27.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Brennan M, Migliorati CA, Lockhart PB, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:S19.e1–S19.e12.Google Scholar
  4. Cabay RJ, Morton TH, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med. 2007;36:255–61.CrossRefPubMedGoogle Scholar
  5. Cavalcante A, Anbinder A, Carvalho Y. Actinic cheilitis: clinical and histological features. J Oral Maxillofac Surg. 2008;66:498–503.CrossRefPubMedGoogle Scholar
  6. D’Souza G, Kreimer A, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.CrossRefPubMedGoogle Scholar
  7. Eversole LR, Eversole GM, Kopcik J. Sanguinaria-associated oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:455–64.CrossRefPubMedGoogle Scholar
  8. Greene FL, Page DL, Pleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.Google Scholar
  9. Haddad R, Annino D, Tishler RB. Multidisciplinary approach to cancer treatment: focus on head and neck cancer. Dent Clin N Am. 2008;52:1–17.CrossRefPubMedGoogle Scholar
  10. Haddad R, Shin D. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143–54.CrossRefPubMedGoogle Scholar
  11. Horowitz AM, Alfano MC. Performing a death-defying act. J Am Dent Assoc. 2001;132:5S–6S.CrossRefPubMedGoogle Scholar
  12. Janfaza P. Surgical anatomy of the head and neck. Hagerstown: Lippincott Williams & Wilkins; 2001.Google Scholar
  13. Johnson NW, Bain CA, et al. Tobacco and oral disease. Br Dent J. 2000;189:200–6.PubMedGoogle Scholar
  14. Lodi G, Sardella A, Bez C. Interventions for treating leukoplakia. Cochrane Database Syst Rev. 2006;18:CD001829.Google Scholar
  15. Maserejian NN, Joshipura KJ, Rosner BA, et al. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev. 2006;15:774–81.CrossRefPubMedGoogle Scholar
  16. Morse DE, Psoter WJ, Cleveland D, et al. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control. 2007;18:919–29.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Munoz AA, Haddad RI, Woo SB, et al. Behavior of oral squamous cell carcinoma in subjects with prior lichen planus. Otolaryngol Head Neck Surg. 2007;136:401–4.CrossRefPubMedGoogle Scholar
  18. Mydlarz WK, Hennessey PT, Califano JA. Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin Med Diagn. 2010;4(1):53–65.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Rodrigo JP, Suarez C, Shaha AR. New molecular diagnostic methods in head and neck cancer. Head Neck. 2005;27:995–1003.CrossRefPubMedGoogle Scholar
  20. Tilakaratne WM, Klinikowski MF, Saku T, et al. Oral submucous fibrosis: a review of aetiology and pathogenesis. Oral Oncol. 2006;42:561–8.CrossRefPubMedGoogle Scholar
  21. Treister NS, Lehmann L, Cherrick I, et al. Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:566–71.CrossRefPubMedGoogle Scholar
  22. Van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification, and present concepts of management. Oral Oncol. 2008;45(4–5):317–23.PubMedGoogle Scholar
  23. Warnakulasuriya S, Reibel J, Boquot J, et al. Oral epithelial dysplasia classification systems: predictive value, utility, weakness, and scope for improvement. J Oral Pathol Med. 2008;37:127–33.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Jean M. Bruch
    • 1
  • Nathaniel S. Treister
    • 2
  1. 1.Massachusetts Eye & Ear InfirmaryHarvard Medical SchoolBostonUSA
  2. 2.Brigham & Women’s Hospital Dana-Farber Cancer Institute Harvard School of Dental MedicineBostonUSA

Personalised recommendations